期刊文献+

激素诱发中心性浆液性脉络膜视网膜病变 被引量:7

Steroids induced central serous choroidoretinopathy
下载PDF
导出
摘要 本文回顾性分析14例(23眼)因全身或眼病而用糖皮质激素(简称激素)治疗过程中,发生中心性浆液性脉络膜视网膜病变(CSC)或大泡性视网膜脱离的病例。症状为视力下降或视物变形。眼底病变均在后极,分为3类:1个或2个泡状半透明视网膜浅脱离;1个或几个视网膜下黄白色渗出,可伴有下方视网膜脱离;大泡性视网膜脱离伴视网膜下灰白色纤维素渗出。所有病例经荧光素眼底血管造影检查显示,后极均见1个或多个色素上皮渗漏点或斑。相干光断层扫描都显示黄斑区神经视网膜脱离或伴有视网膜下高反射物质。这些都符合CSC体征。停用激素后,视网膜在2~10个月内渐复位。其中,浆液性脱离及视网膜下黄白色渗出病例视力恢复良好,达0.5以上;大泡性视网膜脱离最差,在0.1以下。本文详细描述了激素治疗中出现的视力下降情况,并讨论了如何区分是激素用量不足还是激素诱发了CSC。 Data of 14 patients (23 eyes) with central serous choroidoretinaopathy (CSC) or bullous retinal detachment induced by steroids application were analyzed retrospectively. Deterioration of visual acuity (VA) and metamorphosis were major symptoms. Object findings were located at the posterior pole, which included one or two serous translucent shallow retinal detachment (RD); one or several subretinal yellowish exudates some accompanied with inferior shallow RD ;bullous RD with subretinalfibrinous exudates. Fluorescein fundus angiography showed one or several retinal pigment epithelium leakage in all cases. Optical coherence tomography found sensory RD with subretinal hyper- reflecting materials in most cases. All these findings were in accordance with the diagnosis of CSC. Cessation of steroids was undertaken . RD gradually reattached within 2 - 10 months. Among them, cases with serous RD or subretinal yellowish exudates recovered well with final VA 〉0.5. The worst VA was found in bullous RD patients with VA 〈0. I. The paper discussed how to distinquish whether inadequate dosage of steroids or steroids caused worse of VA in steroids induced CSC. (Chin J Ophthalmol and Otorhinolaryngo1,2013,13:2-5)
出处 《中国眼耳鼻喉科杂志》 2013年第1期2-5,共4页 Chinese Journal of Ophthalmology and Otorhinolaryngology
关键词 激素 中心性浆液性视网膜病变 大泡性视网膜脱离 Steroids Central serous choroidoretinaopathy Bullous retinal detachment
  • 相关文献

参考文献12

  • 1Jain IS, Singh K. Maculopathy a corticosteroid side-effect [ J ]. J All India Ophthalmol Soc, 1966, 14(6) : 250-252.
  • 2Williamson J, Dalakos TG. Posterior subcapsular cataracts and macular lesions after long term corticotrophin therapy [ J ]. Br J Ophthalmol, 1967,51 (12) : 839-842.
  • 3Wakakura M, Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment [ J ]. Br J Ophthalmol, 1984,68 (5) : 329-331.
  • 4Gass JD, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous cho-rioretinopathy during systemic corticosteroid therapy [ J ]. Ophthalmology, 1995, 102 ( 5 ) : 737-747.
  • 5Zamir E. Central serous retinopathy associated with adrenocortieotrophic therapy. A case report and new hypothesis [ J ]. Graefes Arch ClinExpOphthalmol, 1997,235(6) : 339-344.
  • 6Bouzas EA, Scott MH, Mastorakos G, et al. Central serous chorioretinopathy in endogenous hypereortisolism [ J ]. Arch Ophthalmol, 1993, 111(9): 1229-1233.
  • 7Chumbley LC, Frank RN. Central serous retinopathy and pregnancy [J]. Am J Ophthalmol, 1974,77(2) : 158-160.
  • 8Kao LY. Bilateral serous retinal detachment resembling central serous chorioretinopathy following epidural steroid injection [ J ]. Retina, 1999,18(5) :479-481.
  • 9Iida T,Spaide RF, Negrao SG, et al. Central serous chorioretinopathy after epidural corticosteroid injection [ J ]. Am J Ophthalmol, 2001, 132(3) : 423-425.
  • 10Haimovici R, Gragoudas ES, Duker JS, et al. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids [J]. Ophthalmology, 1997, 104(10): 1653-1660.

同被引文献40

  • 1苗恒,陶勇,黎晓新.重视眼部移植物抗宿主病的诊断和治疗[J].中华眼科医学杂志(电子版),2014,4(1):1-6. 被引量:7
  • 2Maruko I, Iida T, Ojima A,et al. Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy. Retina 2011; 31(4):759-765.
  • 3Semeraro F, Russo A, Delcassi L, et al. Recurrent central serous chorioretinopathy after peripheral retinal laser photocoagulation: A case report. Eur J Ophthalmol 2013; 23(2):258-261.
  • 4Hagen S, Ansari-Shahrezaei S, Smretschnig E, et al. The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2013; 251(4):1081-1089.
  • 5Quin G, Liew G, Ho IV, et al. Diagnosis and interventions for central serous chorioretinopathy: Review and update. Clin Experiment Ophthalmol 2013; 41(2):187-200.
  • 6Liew G, Quin G, Gillies M, et al. Central serous chorioretinopathy: A review of epidemiology and pathophysiology. Clin Experiment Ophthalmol 2013; 41(2):201-214.
  • 7Sato H, Ito S, Nagai S, et al. A typical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid. Mod Rheumatol 2013; 23(1):172-174.
  • 8Erikitola OC, Crosby-Nwaobi R, Lotery AJ, et al. Photodynamic therapy for central serous chorioretinopathy. Eye(Lond) 2014; 28(8):944-957.
  • 9Fujita K, Yuzawa M, Mori R.et al. Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results. Retina 2011; 31(4):772-778.
  • 10尚庆丽,刘崇哲,魏素琴,史丰,李永军,乔丽敏.中心性浆液性脉络膜视网膜病变患者血浆糖皮质激素及尿类固醇的测定[J].中华眼科杂志,1999,35(4):297-299. 被引量:16

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部